Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)—a randomized trial - Wu, Zhiming; Meng, Peina; Guo, Yajie; You, Wei; Wu, Xiangqi; Ye, Fei (Scientific reports, 2023)
Keywords: 692/4019; 692/4019/2776; Angioplasty; Anticoagulants; Bleeding; Heart; Hemorrhage - etiology; Hirudins; Humanities and Social Sciences; Humans; multidisciplinary; Myocardial Infarction - etiology; Peptide Fragments - adverse effects; Percutaneous Coronary Intervention - adverse effects; Science; Science (multidisciplinary); Treatment Outcome; Troponin I